Status:
COMPLETED
Diagnosis of Gastric Lesions From Exhaled Breath and Saliva
Lead Sponsor:
Anhui Medical University
Collaborating Sponsors:
Technion, Israel Institute of Technology
University of Latvia
Conditions:
Stomach Diseases
Eligibility:
All Genders
18-75 years
Brief Summary
The investigators study the feasibility of a novel method in oncology based on breath analysis with a nanosensors array for identifying gastric diseases. Alveolar exhaled breath samples collected from...
Detailed Description
Number of patients that will have a definitive diagnosis and Alveolar exhaled breath samples collected from individuals with Tedlar® bags (Keika Ventures, LLC) after endoscopy.. Two breath samples wer...
Eligibility Criteria
Inclusion
- 18-75 years
- Gastric cancer, gastric ulcer, gastritis,
- No previous adjuvant treatment (surgery, radiotherapy, chemotherapy)
- Gastric lesions are diagnosed by gastroendoscopy and histopathologic.
- ECOG \< 2
Exclusion
- Other palliative chemotherapy and radiotherapy for this cancer
- Other cancer
- diabetes , Fatty liver
- Autoimmune disease
- Ventilation and transaired function obstacle
Key Trial Info
Start Date :
August 1 2011
Trial Type :
OBSERVATIONAL
Allocation :
ACTUAL
End Date :
January 30 2020
Estimated Enrollment :
1000 Patients enrolled
Trial Details
Trial ID
NCT01420588
Start Date
August 1 2011
End Date
January 30 2020
Last Update
May 8 2020
Active Locations (2)
Enter a location and click search to find clinical trials sorted by distance.
1
Department of Oncology, The First Affiliated Hospital of Anhui Medical University
Hefei, Anhui, China, 230032
2
Faculty of Medicine, University of Latvia
Riga, Latvia, LV1006